Shear-aggregated fibronectin with anti-adhesive properties

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 1, 2011, Pages 20-31

  Branford, O A ^a   Brown, R A ^b   McGrouther, D A ^c   Grobbelaar, A O ^a   Mudera, V ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anti adhesion; Biomaterial; Cell attachment; Fibronectin; Interface; Tendon

Indexed keywords

ADHESION; BIOMATERIALS; BIOMECHANICS; CELL CULTURE; CELL DEATH; FIBROBLASTS; GLASS;

ADHESIVE PROPERTIES; ANTI-ADHESIVE; ANTIADHESION; BIOACTIVE PROPERTIES; CELL ATTACHMENTS; CLINICAL SITUATIONS; DERIVATIVE PROCESS; FLEXOR TENDON; MECHANICAL; TENDON ADHESIONS;

TENDONS;

BIOMATERIAL; FIBRONECTIN;

ANIMAL CELL; ARTICLE; BIODEGRADATION; CELL ADHESION; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; FLEXOR TENDON; IN VITRO STUDY; NONHUMAN; PERITONEUM ADHESION; PHOTOGRAPHY; PRIORITY JOURNAL; RABBIT; SYNOVIUM; TIME LAPSE IMAGING;

EID: 78650274104     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.284     Document Type: Article

References (101)

1. Ahmed Z, Brown RA. 1999; Adhesion, alignment, and migration of cultured Schwann cells on ultrathin fibronectin fibres. Cell Motil Cytoskel 42: 331-343.
2. Ashley FL, McConnell DV, Polak T, et al. 1964; An evaluation of the healing process in avian digital flexor tendons and grafts following the application of an artificial tendon sheath. Plast Reconstr Surg 33: 411-421.
3. Austin RT, Walker F. 1979; Flexor tendon healing and adhesion formation after Sterispon wrapping: a study in the rabbit. Injury 10: 211-216.
4. Beredjiklian PK. 2003; Biologic aspects of flexor tendon laceration and repair. J Bone Joint Surg Am 85A: 539-550.
5. Branford OA, Mudera V, Brown RA, et al. 2008; A novel biomimetic material for engineering postsurgical adhesion using the injured digital flexor tendon-synovial complex as an in vivo model. Plast Reconstr Surg 121: 781-793.
6. Brigman BE, Hu P, Yin H, et al. 1994; Fibronectin in the tendon-synovial complex: quantitation in vivo and in vitro by ELISA and relative mRNA levels by polymerase chain reaction and northern blot. J Orthop Res 12: 253-261.
7. Brown RA. 1983; Failure of fibronectin as an opsonin in the host defence system: a case of competitive self-inhibition? Lancet 2: 1058-1060.
8. Brown RA, Blunn GW, Ejim OS. 1994; Preparation of orientated fibrous mats from fibronectin: composition and stability. Biomaterials 15: 457-464.
9. Burt A, McGrouther DA. 1992; Production and use of skin cell cultures in therapeutic situation. In Animal Cell Biotechnology, Spier RE, Griffiths JB (eds). Academic Press: New York; 158-168.
10. Chung AS, Kao WJ. 2009; Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins. J Biomed Mater Res A 89: 841-853.
11. Clark RA, An JQ, Greiling D, et al. 2003; Fibroblast migration on fibronectin requires three distinct functional domains. J Invest Dermatol 121: 695-705.
12. Clark RA, Wikner NE, Doherty DE, et al. 1988; Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120 kDa fibroblastic cell-binding fragment. J Biol Chem 263: 12115-12123.
13. Cosgriff TM, Hodgson LA, West JV. 1983; The antithrombin III content of cryoprecipitate prepared from blood collected with and without heparin. Vox Sang 44: 98-101.
14. Czop JK, Austen KF. 1982; Augmentation of phagocytosis by a specific fibronectin fragment that links particulate activators to the fibronectin adherence receptor of human monocytes. J Immunol 129: 2678-2681.
15. Darby I, Skalli O, Gabbiani G. 1990; α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63: 21-29.
16. Djerkovic GS, Phillips JB, Brown RA. 2005; Soluble heparin binding fraction from fibronectin tissue engineered scaffold inhibits neuronal growth. 2nd World Congress on Regenerative Medicine, Leipzig, Germany, 18-20 May 2005. Int J Artif Organs 28: 284.
17. Ejim OS, Blunn GW, Brown RA. 1993; Production of artificial-orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials 14: 743-748.
18. Eskeland G, Eskeland T, Hovig T, et al. 1977; The ultrastructure of normal digital flexor tendon sheath and of the tissue formed around silicone and polyethylene implants in man. J Bone Joint Surg Br 59: 206-212.
19. Fukai F, Hasebe S, Ueki M, et al. 1997; Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin. J Biochem (Tokyo) 121: 189-192.
20. Fukai F, Kamiya S, Ohwaki T, et al. 2000; The fibronectin-derived anti-adhesive peptide III14-2 suppresses adhesion and apoptosis of leukemic cell lines through downregulation of protein-tyrosine phosphorylation. Cell Mol Biol (Noisy-le-grand), 46: 145-152.
21. Fukai F, Mashimo M, Akiyama K, et al. 1998; Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp Cell Res 242: 92-99.
22. Fukai F, Ohtaki M, Fujii N, et al. 1995; Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry 34: 11453-11459.
23. Fukai F, Takahashi H, Habu Y, et al. 1996; Fibronectin harbors anticell adhesive activity. Biochem Biophys Res Commun 220: 394-398.
24. Gelberman RH, Steinberg D, Amiel D, et al. 1991; Fibroblast chemotaxis after tendon repair. J Hand Surg Am 16: 686-693.
25. Golash A, Kay A, Warner JG, et al. 2003; Efficacy of ADCON-T/N after primary flexor tendon repair in Zone II: a controlled clinical trial. J Hand Surg Br 28: 113-115.
26. Grinnell F. 1984; Fibronectin and wound healing. J Cell Biochem 26: 107-116.
27. Grinnell F, Ho CH, Wysocki A. 1992; Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98: 410-416.
28. Grinnell F, Zhu M. 1994; Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 103: 155-161.
29. Hanff G, Hagberg L. 1998; Prevention of restrictive adhesions with expanded polytetrafluoroethylene diffusible membrane following flexor tendon repair: an experimental study in rabbits. J Hand Surg Am 23: 658-664.
30. Harding SI, Afoke A, Brown RA, et al. 2002; Engineering and cell attachment properties of human fibronectin-fibrinogen scaffolds for use in tissue engineered blood vessels. Bioprocess Biosyst Eng 25: 53-59.
31. Harding SI, Underwood S, Brown RA, et al. 2000; Assessment of cell alignment by fibronectin multifibre cables capable of large scale production. Bioprocess Eng 22: 159-164.
32. Harris AK, Stopak D, Wild P. 1981; Fibroblast traction as a mechanism for collagen morphogenesis. Nature 290: 249-251.
33. Hautanen A, Gailit J, Mann DM, et al. 1989; Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem 264: 1437-1442.
34. Hiraizumi Y, Transfeldt EE, Fujimaki E, et al. 1995; Application of polyvinyl alcohol hydrogel membrane as anti-adhesive interposition after spinal surgery. Spine (Phila Pa 1976) 20: 2272-2277.
35. Hofer U, Syfrig J, Chiquet-Ehrismann R. 1990; Identification and characterization of a dimeric chicken fibronectin receptor. Subunit-specific monoclonal antibodies to the putative chicken α5β1 integrin. J Biol Chem 265: 14561-14565.
36. Holmdahl L. 1999; Making and covering of surgical footprints. Lancet 353: 1456-14567.
37. Homandberg GA. 1987; Characterization of the interactions of an amino-terminal fibronectin fragment with the native molecule: implications for polymerization of fibronectin. Biopolymers 26: 2087-2098.
38. Homandberg GA, Kramer-Bjerke J, Grant D, et al. 1986; Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth: structure-function correlations. Biochim Biophys Acta 874: 61-71.
39. Homandberg GA, Meyers R, Xie DL. 1992; Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 267: 3597-3604.
40. Jeekel H. 1997; Cost implications of adhesions as highlighted in a European study. Eur J Surg Suppl 163: 43-45.
41. Johansson S, Svineng G, Wennerberg K, et al. 1997; Fibronectin-integrin interactions. Front Biosci 2: d126-146.
42. Kato R, Kamiya S, Ueki M, et al. 2001; The fibronectin-derived antiadhesive peptides suppress the myofibroblastic conversion of rat hepatic stellate cells. Exp Cell Res 265: 54-63.
43. Khan U, Edwards JC, McGrouther DA. 1996; Patterns of cellular activation after tendon injury. J Hand Surg Br 21: 813-820.
44. Khan U, Kakar S, Akali A, et al. 2000; Modulation of the formation of adhesions during the healing of injured tendons. J Bone Joint Surg Br 82: 1054-1058.
45. Khan U, Occleston NL, Khaw PT, et al. 1997; Single exposures to 5-fluorouracil: a possible mode of targeted therapy to reduce contractile scarring in the injured tendon. Plast Reconstr Surg 99: 465-471.
46. Khan U, Occleston NL, Khaw PT, et al. 1998; Differences in proliferative rate and collagen lattice contraction between endotenon and synovial fibroblasts. J Hand Surg Am 23: 266-273.
47. King VR, Henseler M, Brown RA, et al. 2003; Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Exp Neurol 182: 383-398.
48. Kitsis CK, Wade PJ, Krikler SJ, et al. 1998; Controlled active motion following primary flexor tendon repair: a prospective study over 9 years. J Hand Surg Br 23: 344-349.
49. Kulick MI, Smith S, Hadler K. 1986; Oral ibuprofen: evaluation of its effect on peritendinous adhesions and the breaking strength of a tenorrhaphy. J Hand Surg Am 11: 110-120.
50. Liakakos T, Thomakos N, Fine PM, et al. 2001; Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 18: 260-273.
51. McCarthy JB, Skubitz AP, Qi Z, et al. 1990; RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities. J Cell Biol 110: 777-787.
52. Menzies D, Ellis H. 1990; Intestinal obstruction from adhesions-how big is the problem? Ann R Coll Surg Engl 72: 60-63.
53. Menzies D, Parker M, Hoare R, et al. 2001; Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl 83: 40-46.
54. Meredith JE Jr, Schwartz MA. 1997; Integrins, adhesion and apoptosis. Trends Cell Biol 7: 146-150.
55. Mooradian DL, McCarthy JB, Cameron JD, et al. 1992; Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin. Invest Ophthalmol Vis Sci 33: 3034-3040.
56. Mould AP, Humphries MJ. 1991; Identification of a novel recognition sequence for the integrin α4β1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J 10: 4089-4095.
57. Mutsaers SE, Bishop JE, McGrouther G, et al. 1997; Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29: 5-17.
58. Obara M, Kang MS, Yamada KM. 1988; Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell 53: 649-657.
59. Oharazawa H, Ibaraki N, Ohara K, et al. 2005; Inhibitory effects of Arg-Gly-Asp (RGD) peptide on cell attachment and migration in a human lens epithelial cell line. Ophthalmic Res 37: 191-196.
60. Peck FH, Bucher CA, Watson JS, et al. 1998; A comparative study of two methods of controlled mobilization of flexor tendon repairs in zone 2. J Hand Surg Br 23: 41-45.
61. Peterson WW, Manske PR, Dunlap J, et al. 1990; Effect of various methods of restoring flexor sheath integrity on the formation of adhesions after tendon injury. J Hand Surg Am 15: 48-56.
62. Phillips JB, King VR, Ward Z, et al. 2004; Fluid shear in viscous fibronectin gels allows aggregation of fibrous materials for CNS tissue engineering. Biomaterials 25: 2769-2779.
63. Pierschbacher MD, Ruoslahti E. 1984a; Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30-33.
64. Pierschbacher MD, Ruoslahti E. 1984b; Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci USA 81: 5985-5988.
65. Potenza AD. 1962; Tendon healing within the flexor digital sheath in the dog. J Bone Joint Surg Am 44A: 49-64.
66. Potenza AD. 1963; Critical evaluation of flexor-tendon healing and adhesion formation within artificial digital sheaths. J Bone Joint Surg Am 45: 1217-1233.
67. Priestley JV, Ramer MS, King VR, et al. 2002; Stimulating regeneration in the damaged spinal cord. J Physiol Paris 96: 123-133.
68. Ragoowansi R, Khan U, Brown RA, et al. 2003; Differences in morphology, cytoskeletal architecture and protease production between zone II tendon and synovial fibroblasts in vitro. J Hand Surg Br 28: 465-470.
69. Riederer-Henderson MA, Gauger A, Olson L, et al. 1983; Attachment and extracellular matrix differences between tendon and synovial fibroblastic cells. In Vitro 19: 127-133.
70. Rocco M, Carson M, Hantgan R, et al. 1983; Dependence of the shape of the plasma fibronectin molecule on solvent composition. Ionic strength and glycerol content. J Biol Chem 258: 14545-14549.
71. Ruoslahti E. 1996; RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715.
72. Ruoslahti E, Hayman EG, Engvall E, et al. 1981; Alignment of biologically active domains in the fibronectin molecule. J Biol Chem 256: 7277-7281.
73. Ruoslahti E, Hayman EG, Pierschbacher M, et al. 1982; Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol 82A: 803-831.
74. Sakata N, Sasatomi Y, Meng J, et al. 2000; Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation and product-modified fibronectin to vascular smooth muscle cells. Connect Tissue Res 41: 213-228.
75. Scovill WA, Saba TM, Blumenstock FA, et al. 1978; Opsonic α2 surface binding glycoprotein therapy during sepsis. Ann Surg 188: 521-529.
76. Sethi KK, Mudera V, Sutterlin R, et al. 2002; Contraction-mediated pinocytosis of RGD-peptide by dermal fibroblasts: inhibition of matrix attachment blocks contraction and disrupts microfilament organization. Cell Motil Cytoskel 52: 231-241.
77. Shimo-Oka T, Hasegawa Y, Ii I. 1988; Differential properties of attachment of human fibroblasts to various extracellular matrix proteins. Cell Struct Funct 13: 515-524.
78. Siddiqi NA, Hamada Y, Ide T, et al. 1995; Effects of hydroxyapatite and alumina sheaths on postoperative peritendinous adhesions in chickens. J Appl Biomater 6: 43-53.
79. Skorstengaard K, Jensen MS, Petersen TE, et al. 1986; Purification and complete primary structures of the heparin-, cell- and DNA-binding domains of bovine plasma fibronectin. Eur J Biochem 154: 15-29.
80. Stack MS, Pizzo SV. 1993; Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin. J Biol Chem 268: 18924-18928.
81. Stadelmann WK, Digenis AG, Tobin GR. 1998; Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 176: 26-38S.
82. Stark HH, Boyes JH, Johnson L, et al. 1977; The use of paratenon, polyethylene film, or silastic sheeting to prevent restricting adhesions to tendons in the hand. J Bone Joint Surg Am 59: 908-913.
83. Strickland JW. 1985; Results of flexor tendon surgery in zone II. Hand Clin 1: 167-179.
84. Strickland JW. 2000; Development of flexor tendon surgery: 25 years of progress. J Hand Surg Am 25: 214-235.
85. Thomas SC, Jones LC, Hungerford DS. 1986; Hyaluronic acid and its effect on postoperative adhesions in the rabbit flexor tendon. A preliminary look. Clin Orthop Relat Res 206: 281-289.
86. Tsukada H, Ying X, Fu C, et al. 1995; Ligation of endothelial αvβ3 integrin increases capillary hydraulic conductivity of rat lung. Circ Res 77: 651-659.
87. Underwood S, Afoke A, Brown RA, et al. 2001; Wet extrusion of fibronectin-fibrinogen cables for application in tissue engineering. Biotechnol Bioeng 73: 295-305.
88. van der Flier A, Sonnenberg A. 2001; Function and interactions of integrins. Cell Tissue Res 305: 285-298.
89. Watanabe K, Takahashi H, Habu Y, et al. 2000; Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin. Biochemistry 39: 7138-7144.
90. Werb Z, Tremble PM, Behrendtsen O, et al. 1989; Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109: 877-889.
91. Whitby DJ, Ferguson MW. 1991; The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 112: 651-668.
92. Whitworth IH, Brown RA, Dore C, et al. 1995; Orientated mats of fibronectin as a conduit material for use in peripheral nerve repair. J Hand Surg Br 20: 429-436.
93. Wilke MS, Skubitz AP, Furcht LT, et al. 1991; Human keratinocytes adhere to two distinct heparin-binding synthetic peptides derived from fibronectin. J Invest Dermatol 97: 573-579.
94. Williams DF. 1999; The Williams Dictionary of Biomaterials, Liverpool University Press: Liverpool, UK.
95. Wojciak-Stothard B, Denyer M, Mishra M, et al. 1997; Adhesion, orientation, and movement of cells cultured on ultrathin fibronectin fibers. In Vitro Cell Dev Biol Anim 33: 110-117.
96. Yamada KM. 1983; Cell surface interactions with extracellular materials. Annu Rev Biochem 52: 761-799.
97. Yamada KM, Kennedy DW. 1984; Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J Cell Biol 99: 29-36.
98. Yamada KM, Kennedy DW. 1987; Peptide inhibitors of fibronectin, laminin, and other adhesion molecules: unique and shared features. J Cell Physiol 130: 21-28.
99. Zavahir F, McGrouther DA, Misra A, et al. 2001; A study of the cellular response to orientated fibronectin material in healing extensor rat tendon. J Mater Sci Mater Med 12: 1005-1011.
100. Zlatopol'skiǐ AD, Chubukina AN, Zaidenberg MA. 1989; The effect of fibronectin fragments on proliferative activity of fibroblasts. Biokhimiia 54: 74-80.
101. Zlatopol'skiǐ AD, Chubukina AN, Berman AE. 1992; Heparin-binding fibronectin fragments containing cell-binding domains and devoid of hep2 and gelatin-binding domains promote human embryo fibroblast proliferation. Biochem Biophys Res Commun 183: 383-389.